Clinical Trial Update: Emapalumab Efficacy in Children With Primary Hemophagocytic Lymphohistiocytosis

View source ↗

Summary

Clinical trial update on the efficacy of emapalumab in children with primary Hemophagocytic Lymphohistiocytosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• Emapalumab (emapalumab)

Snippet

Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology | Conditions: Primary Hemophagocytic Lymphohistiocytosis | Status: ACTIVE_NOT_RECRUITING